XML 28 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenue $ 6,000 $ 2,000
Cost of revenue 680 60
Gross profit 5,320 1,940
Operating expenses:      
Research and development expenses, net 28,694 22,760 19,816
Marketing and business development expenses 842 871 651
General and administrative expenses 10,858 9,805 8,412
Total operating expenses 40,394 33,436 28,879
Operating loss (35,074) (31,496) (28,879)
Financial and other income, net 871 1,798 820
Loss before taxes on income (34,203) (29,698) (28,059)
Taxes on income 722
Net loss $ (34,203) $ (29,698) $ (27,337)
Basic net loss per share $ (0.41) $ (0.37) $ (0.43)
Diluted net loss per share $ (0.41) $ (0.37) $ (0.43)
Total comprehensive loss $ (34,203) $ (29,698) $ (27,337)
Weighted average number of ordinary shares used in computing basic net loss per share 84,203,971 79,591,187 63,636,673
Weighted average number of ordinary shares used in computing diluted net loss per share 84,203,971 79,591,187 63,636,673